Immunoblot analyses revealed that LOXL2 was present in the serum exosomal fractions from three HNSCC patients, and Sanada et al. observed approximately threefold higher levels of LOXL2 in the HNSCC patients compared with three healthy volunteers. The gene discussed is LOXL2; the disease is head and neck squamous cell carcinoma.